• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

建模 SARS-CoV-2 的 XBB 株:变种之间的竞争和再感染的影响。

Modeling the XBB strain of SARS-CoV-2: Competition between variants and impact of reinfection.

机构信息

School of Mathematics, Hefei University of Technology, Hefei, Anhui 230009, China.

School of Mathematical Sciences, University of Science and Technology of China, Hefei, Anhui 230026, China.

出版信息

J Theor Biol. 2023 Oct 7;574:111611. doi: 10.1016/j.jtbi.2023.111611. Epub 2023 Aug 26.

DOI:10.1016/j.jtbi.2023.111611
PMID:37640233
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10592017/
Abstract

XBB, an Omicron subvariant of SARS-CoV-2 that began to circulate in late 2022, has been dominant in the US since early 2023. To quantify the impact of XBB on the progression of COVID-19, we propose a new mathematical model which describes the interplay between XBB and other SARS-CoV-2 variants at the population level and which incorporates the effects of reinfection. We apply the model to COVID-19 data in the US that include surveillance data on the cases and variant proportions from the New York City, the State of New York, and the State of Washington. Our fitting and simulation results show that the transmission rate of XBB is significantly higher than that of other variants and the reinfection from XBB may play an important role in shaping the pandemic/epidemic pattern in the US.

摘要

XBB,一种奥密克戎的 SARS-CoV-2 亚变种,于 2022 年末开始传播,自 2023 年初以来已成为美国的主要流行株。为了量化 XBB 对 COVID-19 进展的影响,我们提出了一个新的数学模型,该模型描述了 XBB 与其他 SARS-CoV-2 变体在人群水平上的相互作用,并纳入了再感染的影响。我们将该模型应用于美国的 COVID-19 数据,其中包括来自纽约市、纽约州和华盛顿州的病例和变体比例的监测数据。我们的拟合和模拟结果表明,XBB 的传播率明显高于其他变体,而 XBB 的再感染可能在美国大流行/疫情模式中发挥重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e46/10592017/3796934eb906/nihms-1927453-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e46/10592017/0d108b79d3d2/nihms-1927453-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e46/10592017/ed378b5cce76/nihms-1927453-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e46/10592017/9ff78db107eb/nihms-1927453-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e46/10592017/a51de318b045/nihms-1927453-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e46/10592017/e582e06c568c/nihms-1927453-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e46/10592017/e124869bf56a/nihms-1927453-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e46/10592017/3796934eb906/nihms-1927453-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e46/10592017/0d108b79d3d2/nihms-1927453-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e46/10592017/ed378b5cce76/nihms-1927453-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e46/10592017/9ff78db107eb/nihms-1927453-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e46/10592017/a51de318b045/nihms-1927453-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e46/10592017/e582e06c568c/nihms-1927453-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e46/10592017/e124869bf56a/nihms-1927453-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e46/10592017/3796934eb906/nihms-1927453-f0007.jpg

相似文献

1
Modeling the XBB strain of SARS-CoV-2: Competition between variants and impact of reinfection.建模 SARS-CoV-2 的 XBB 株:变种之间的竞争和再感染的影响。
J Theor Biol. 2023 Oct 7;574:111611. doi: 10.1016/j.jtbi.2023.111611. Epub 2023 Aug 26.
2
Protective immunity of SARS-CoV-2 infection and vaccines against medically attended symptomatic omicron BA.4, BA.5, and XBB reinfections in Singapore: a national cohort study.新加坡一项全国性队列研究:SARS-CoV-2 感染和疫苗对有医疗记录的奥密克戎 BA.4、BA.5 和 XBB 再感染相关症状的保护免疫作用。
Lancet Infect Dis. 2023 Jul;23(7):799-805. doi: 10.1016/S1473-3099(23)00060-9. Epub 2023 Mar 13.
3
Genomic Surveillance Reveals the Rapid Expansion of the XBB Lineage among Circulating SARS-CoV-2 Omicron Lineages in Southeastern Wisconsin, USA.基因组监测揭示了美国威斯康星州东南部流行的 SARS-CoV-2 奥密克戎谱系中 XBB 谱系的快速扩张。
Viruses. 2023 Sep 16;15(9):1940. doi: 10.3390/v15091940.
4
Relative vaccine protection, disease severity, and symptoms associated with the SARS-CoV-2 omicron subvariant BA.2.86 and descendant JN.1 in Denmark: a nationwide observational study.丹麦全国性观察研究:与 SARS-CoV-2 奥密克戎亚变体 BA.2.86 和后代 JN.1 相关的相对疫苗保护、疾病严重程度和症状。
Lancet Infect Dis. 2024 Sep;24(9):964-973. doi: 10.1016/S1473-3099(24)00220-2. Epub 2024 May 15.
5
A New-fangled COVID-19 Variant, Eris, Might be the One to Lookout in 2023 or far from Over.一种新型的 COVID-19 变体,Eris,可能是 2023 年需要关注的对象,亦或尚未结束。
Infect Disord Drug Targets. 2024;24(6):e220124225916. doi: 10.2174/0118715265276833240105110046.
6
Editorial: The XBB.1.5 ('Kraken') Subvariant of Omicron SARS-CoV-2 and its Rapid Global Spread.社论:奥密克戎 SARS-CoV-2 的 XBB.1.5(“Kraken”)亚变体及其快速全球传播。
Med Sci Monit. 2023 Feb 1;29:e939580. doi: 10.12659/MSM.939580.
7
Genomic surveillance and vaccine response to the dominant SARS-CoV-2 XBB lineage in Rio Grande do Sul.基因组监测和针对南里奥格兰德州主要 SARS-CoV-2 XBB 谱系的疫苗反应。
Sci Rep. 2024 Jul 22;14(1):16831. doi: 10.1038/s41598-024-67828-7.
8
Comprehensive Analysis of Omicron Subvariants: EG.5 Rise, Vaccination Strategies, and Global Impact.奥密克戎亚型的综合分析:例如,EG.5 崛起、疫苗接种策略和全球影响。
Curr Drug Targets. 2024;25(8):517-525. doi: 10.2174/0113894501296586240430061915.
9
Prevalence of symptoms, comorbidities, and reinfections in individuals infected with Wild-Type SARS-CoV-2, Delta, or Omicron variants: a comparative study in western Mexico.在墨西哥西部,比较感染野生型 SARS-CoV-2、Delta 或 Omicron 变异株的个体的症状、合并症和再感染的流行情况:一项比较研究。
Front Public Health. 2023 Apr 27;11:1149795. doi: 10.3389/fpubh.2023.1149795. eCollection 2023.
10
Impact of mutations in SARS-CoV-2 recombinant sub-variant XBB.1.16 on the binding affinity with human ACE2 receptor.SARS-CoV-2 重组子变体 XBB.1.16 突变对其与人 ACE2 受体结合亲和力的影响。
J Mol Graph Model. 2024 Sep;131:108813. doi: 10.1016/j.jmgm.2024.108813. Epub 2024 Jun 13.

引用本文的文献

1
Emergence to dominance: Estimating time to dominance of SARS-CoV-2 variants using nonlinear statistical models.崛起至主导地位:使用非线性统计模型估计新冠病毒变异株占据主导地位的时间。
PLoS One. 2025 Apr 2;20(4):e0311459. doi: 10.1371/journal.pone.0311459. eCollection 2025.

本文引用的文献

1
A multi-strain model with asymptomatic transmission: Application to COVID-19 in the US.具有无症状传播的多菌株模型:在 COVID-19 于美国的应用。
J Theor Biol. 2023 May 21;565:111468. doi: 10.1016/j.jtbi.2023.111468. Epub 2023 Mar 20.
2
Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis.既往 SARS-CoV-2 感染对再感染的保护作用:系统评价和荟萃分析。
Lancet. 2023 Mar 11;401(10379):833-842. doi: 10.1016/S0140-6736(22)02465-5. Epub 2023 Feb 16.
3
Imprinted hybrid immunity against XBB reinfection.针对XBB再感染的印记杂交免疫。
Lancet Infect Dis. 2023 Jul;23(7):764-765. doi: 10.1016/S1473-3099(23)00138-X. Epub 2023 Mar 13.
4
Editorial: The XBB.1.5 ('Kraken') Subvariant of Omicron SARS-CoV-2 and its Rapid Global Spread.社论:奥密克戎 SARS-CoV-2 的 XBB.1.5(“Kraken”)亚变体及其快速全球传播。
Med Sci Monit. 2023 Feb 1;29:e939580. doi: 10.12659/MSM.939580.
5
The impact of cross-reactive immunity on the emergence of SARS-CoV-2 variants.交叉免疫反应对 SARS-CoV-2 变体出现的影响。
Front Immunol. 2023 Jan 11;13:1049458. doi: 10.3389/fimmu.2022.1049458. eCollection 2022.
6
The COVID-19 immunology masterclass enters its fourth year.2019冠状病毒病免疫学大师班进入第四个年头。
Nat Immunol. 2023 Feb;24(2):201-202. doi: 10.1038/s41590-022-01393-x.
7
Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave.奥密克戎变异株流行期间 SARS-CoV-2 突破性感染和再感染的传染性。
Nat Med. 2023 Feb;29(2):358-365. doi: 10.1038/s41591-022-02138-x. Epub 2023 Jan 2.
8
Mathematical Models for Cholera Dynamics-A Review.霍乱动力学的数学模型——综述
Microorganisms. 2022 Nov 29;10(12):2358. doi: 10.3390/microorganisms10122358.
9
SARS-CoV-2 and COVID-19: A Narrative Review.SARS-CoV-2 和 COVID-19:一个叙事性回顾。
Br J Biomed Sci. 2022 Sep 6;79:10426. doi: 10.3389/bjbs.2022.10426. eCollection 2022.
10
Awareness of SARS-CoV-2 Omicron Variant Infection Among Adults With Recent COVID-19 Seropositivity.奥密克戎变异株感染的知晓情况在近期新冠血清阳性的成年人中。
JAMA Netw Open. 2022 Aug 1;5(8):e2227241. doi: 10.1001/jamanetworkopen.2022.27241.